Biophytis Stock Total Debt
Biophytis fundamentals help investors to digest information that contributes to Biophytis' financial success or failures. It also enables traders to predict the movement of Biophytis Stock. The fundamental analysis module provides a way to measure Biophytis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biophytis stock.
Biophytis |
Biophytis Company Total Debt Analysis
Biophytis' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Biophytis Total Debt | 8.27 M |
Most of Biophytis' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biophytis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Biophytis has a Total Debt of 8.27 M. This is 99.7% lower than that of the Biotechnology sector and 97.45% lower than that of the Health Care industry. The total debt for all United States stocks is 99.84% higher than that of the company.
Biophytis Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biophytis' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biophytis could also be used in its relative valuation, which is a method of valuing Biophytis by comparing valuation metrics of similar companies.Biophytis is currently under evaluation in total debt category among its peers.
Biophytis Fundamentals
| Return On Equity | -12.44 | |||
| Return On Asset | -0.53 | |||
| Current Valuation | 9.73 B | |||
| Shares Outstanding | 286.5 K | |||
| Shares Owned By Institutions | 0.04 % | |||
| Number Of Shares Shorted | 368.95 K | |||
| Price To Book | 2.26 X | |||
| EBITDA | (15.09 M) | |||
| Net Income | (17.03 M) | |||
| Cash And Equivalents | 23.93 M | |||
| Cash Per Share | 1.71 X | |||
| Total Debt | 8.27 M | |||
| Debt To Equity | 3.27 % | |||
| Current Ratio | 1.37 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (13.33 M) | |||
| Short Ratio | 0.41 X | |||
| Earnings Per Share | (128.39) X | |||
| Target Price | 6000.0 | |||
| Number Of Employees | 22 | |||
| Beta | 1.05 | |||
| Market Capitalization | 2.61 M | |||
| Total Asset | 11.94 M | |||
| Retained Earnings | (19.38 M) | |||
| Working Capital | (3.52 M) | |||
| Net Asset | 11.94 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Biophytis Stock
If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |